Clodronic acid reaps benefit in metastatic bone disease

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.557, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clodronic acid reduces bone metastases

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Ibandronic acid beneficial in metastatic bone disease

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Effects of Two Administration Schemes of Intramuscular Clodronic Acid on Bone Mineral Density: A Randomized, Open-Label, Parallel-Group Study

By Frediani Bruno

Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. : 43-50

Adis International

Access to resources Recommend Favorite

Clodronic Acid in the Treatment of Postmenopausal Osteoporosis

By Tanakol Refik

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 419-433

Adis International

Access to resources Recommend Favorite

Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease

By Lyubimova N.V.

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 707-716

Adis International

Access to resources Recommend Favorite